InVivoBridge is an independent consulting and coordination company
supporting early-stage biotech teams in preclinical development.
We connect science and strategy helping innovators design, plan, and
coordinate in vivo studies across trusted European partners.
Dr. Sajida Kanwal is an infection biologist and preclinical strategist with over a decade of experience in coordinating in vivo model development, vaccine immunology, and translational research across Germany and the Netherlands.
She founded InVivoBridge to help biotech innovators bring scientific precision and regulatory structure to their preclinical programs bridging the gap between ideas and execution.
10+ years of experience in infection biology & vaccine research
Cross-border experience
in Germany &
the Netherlands
FELASA B certified
in vivo
experimentation
Marie Skłodowska-Curie Postdoctoral Fellow (EU Horizon Program)
Coordinated multi-
partner CRO–academic consortia
Expertise in mucosal immunology, imaging models & vaccine kinetics
Where scientific precision meets structured coordination.
Every project at InVivoBridge is guided by clear communication, regulatory
awareness, and a structured project plan.
We ensure that biotech teams get unbiased scientific guidance, transparent
updates, and harmonized execution turning preclinical complexity into clarity.
bridge between biotech innovation and
preclinical execution — advancing therapies
from idea to in vivo impact.
Trusted feedback from CRO and academic collaborators who worked with
InVivoBridge.
Client and partner experiences reflect the structure, transparency, and
scientific precision that InVivoBridge brings to every preclinical program.
Our collaborators appreciate the clarity, coordination, and compliance that
define our consulting approach.
“Sajida is an exceptionally organized and reliable collaborator. Her ability to coordinate cross-disciplinary and international projects, coupled with her clear communication and proactive initiative, makes her an invaluable asset to any team. She consistently ensures projects stay on track with thorough follow-up”.
— Jonas Feuner, CEO preclinics GmbH, Potsdam, Germany
— Prof. Dr. Marien de Jonge, Head of Laboratory of Medical Immunology, RUMC, Nijmegen, The Netherlands.
I have had the pleasure of working with Dr. Sajida Kanwal both as her PhD supervisor and later as a collaborator within an international nanobody consortium. She combines solid scientific depth with strong organizational and communication skills. Dr. Kanwal has demonstrated a valuable ability to bring together partners from different disciplines and institutions, contributing to the efficient coordination of complex research projects. Her analytical thinking, reliability, and commitment make her a dependable link between academic and translational research environments.
— Prof. Dr. Sven Hammerschmidt, Chair of CFGM. University of Greifswald, Germany
Let’s align science, strategy, and execution to accelerate your next in vivo program efficiently and compliantly across Europe.
Study Coordination
Regulatory Support
CRO + Academic Collaboration
Integrated Reporting
Immunology Model Access